XML 67 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingent Liabilities - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
May 17, 2013
USD ($)
Oct. 31, 2020
USD ($)
company
Dec. 31, 2020
USD ($)
stateAttorney
case
state
Dec. 31, 2020
USD ($)
stateAttorney
case
state
Mar. 31, 2020
county
Jan. 14, 2020
company
Dec. 31, 2019
county
Aug. 13, 2019
fax_number
fax
Apr. 30, 2018
USD ($)
Dec. 30, 2017
investmentFund
Dec. 29, 2017
investmentFund
Loss Contingencies [Line Items]                      
Number of counties that filed claims | county             2        
Aggregate annual surcharge on licensed manufacturers and distributors of opioids                 $ 100,000,000    
Pre-tax accrual     $ 50,000,000 $ 50,000,000              
After-tax accrual     37,000,000 37,000,000              
National Prescription Opioid Litigation                      
Loss Contingencies [Line Items]                      
Pre-tax expenses related to estimated litigation liability     8,100,000,000 8,100,000,000              
After-tax expenses related to estimated litigation liability     $ 6,700,000,000 $ 6,700,000,000              
National Prescription Opioid Litigation                      
Loss Contingencies [Line Items]                      
Complaints filed against the entity | case     2,900 2,900              
True Health Chiropractic Inc., et al. v. McKesson Corporation, et al                      
Loss Contingencies [Line Items]                      
Number of faxes remaining in the class | fax_number               9,490      
Number of faxes received | fax               48,769      
True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum                      
Loss Contingencies [Line Items]                      
Statutory damages sought per violation $ 500                    
True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum                      
Loss Contingencies [Line Items]                      
Statutory damages sought per violation $ 1,500                    
Polygon European Equity Opportunity Master Fund et al. v. McKesson Europe Holdings GmbH & Co. KGaA                      
Loss Contingencies [Line Items]                      
Number of investment funds that filed claims | investmentFund                   4 2
Canada                      
Loss Contingencies [Line Items]                      
Complaints filed against the entity | case     3 3              
Pending                      
Loss Contingencies [Line Items]                      
Complaints filed against the entity | case     400 400              
Number of states in which court cases are pending | state     38 38              
Number of attorney generals that have filed claims | stateAttorney     26 26              
Number of county government plaintiffs | county         2            
Pending | National Prescription Opioid Litigation                      
Loss Contingencies [Line Items]                      
Number of cases selected for possible remand to other federal courts | case     3 3              
Award payable under proposed framework   $ 8,000,000,000.0                  
Settlement award anticipated to be used to remediate the opioid crisis (percent)   90.00%                  
Pending | Canada                      
Loss Contingencies [Line Items]                      
Complaints filed against the entity | case     3 3              
Pending | Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation                      
Loss Contingencies [Line Items]                      
Number of largest pharmaceutical distributors to adopt anti-diversion programs under proposed framework | company   3       3          
Award payable under proposed framework   $ 21,000,000,000.0                  
Period over which award would be payable under proposed framework   18 years